21DNA polymerase IV (pol IV) is expressed at increased levels in Escherichia coli cells 22 suffering high levels of DNA damage. In a recent single-molecule imaging study, we 23 demonstrated that elevating the pol IV concentration is not sufficient to provide access to binding 24 sites on the nucleoid, suggesting that other factors may recruit pol IV to its substrates once the 25 DNA becomes damaged. Here we extend this work, investigating the proteins UmuD and RecA 26 as potential modulators of pol IV activity. UmuD promotes long-lived association of pol IV with 27 the nucleoid, whereas its cleaved form, UmuDʹ, which accumulates in DNA-damaged cells, 28 109 UmuD in cells treated with the DNA damaging antibiotic ciprofloxacin. In contrast, UmuD′ 110 diminishes pol IV binding. We observed that a large proportion of pol IV foci (up to 40%) 111 colocalise with a RecA* marker in ciprofloxacin-treated cells. The recA(E38K) mutation (also 112 6 known as recA730), which constitutively produces RecA*-like activity (Cazaux et al., 1993; 113 Wang et al., 1993; Ennis et al., 1995), promotes the binding activity of pol IV to the nucleoid, 114 even in the absence of DNA damage. We further showed that pol IV physically interacts with 115 RecA(E38K), which forms RecA*-like structures on single-stranded as well as double-stranded 116 DNA, suggesting that pol IV might also associate with these RecA*-like structures in cells.
117These findings provide evidence for regulatory roles for both UmuD and RecA in modulating the 118 binding activity of pol IV in E. coli cells. RecA* structures that likely mark sites of on-going 119 DSB repair appear to serve as major binding sites for pol IV in live cells treated with 120 ciprofloxacin.
121
Results
122Deletion of umuDC increases pol IV- colocalisation 123 In a previous study, we carried out time-lapse measurements on E. coli cells treated with 124 DNA damaging agents (Henrikus et al., 2018b). We found that the colocalisation of pol IV foci 125 with replisome markers started at ~10% prior to treatment, and dropped to < 5% (i.e. baseline 126 levels) at a time-point 90-100 after the onset of treatment. In a separate study, we observed that 127 pol V (UmuC-mKate2) enters the cytosol and forms foci on the nucleoid at this same 90 min 128 time-point (Robinson et al., 2015). This spatial re-distribution of the UmuC-mKate2 marker 129 required cleavage of UmuD to UmuD′. The similar timing of the changes in pol IV and pol V 130 localisation, together with established links between pol IV activity and UmuD/UmuD′ status 131 described above, led us to hypothesise that UmuD cleavage and/or formation of pol V at the 90 132 min time-point alters the colocalisation of pol IV with replisome markers.133To investigate the effect of pol V and/or its precursors (UmuD and UmuC) on the extent 134 of pol IV focus formation and colocalisation with a replisome marker, we constructed two 135 7 strains: i) dinB-YPet dnaX-mKate2 umuDC + (EAW643, (Henrikus et al., 2018b)) and ii) dinB-136 YPet dnaX-mKate2...